Indeed, the former group is characterized clinically by a poor glycaemic control, higher insulin requirement, and longer diabetes duration, while the latter is identified by a metabolic syndrome phenotype with insulin-resistance and with a higher prevalence of dyslipidaemia and LDL-cholesterol level, genetic predisposition and obesity [21]. This evidence concerns the gene INS and Insulin resistance.